| 1999 |
Crystal structure of PIN/LC8 (DYNLL1) dimer reveals two monomers forming a rectangular dimer with two pairs of alpha-helices covering opposite faces, each packing against a five-stranded antiparallel beta-sheet (four strands from one monomer, one from the other). A 13-residue nNOS peptide binds in a deep hydrophobic groove at the dimer interface as a sixth antiparallel beta-strand, providing structural basis for dimerization and peptide binding. |
X-ray crystallography |
Nature structural biology |
High |
10426949
|
| 2001 |
LC8 (DYNLL1) exists as a reversible monomer-dimer equilibrium with a dissociation constant of ~12 µM at pH 7; dimerization is pH-dependent, with dissociation to monomer below pH ~4.8, attributable to titration of a histidine pair at the dimer interface. Unfolding is a two-stage process: dimer dissociation to folded monomer precedes global unfolding. |
Analytical ultracentrifugation, size-exclusion chromatography, circular dichroism, fluorescence spectroscopy |
Biochemistry |
High |
11327818
|
| 2007 |
LC8 (DYNLL1) binds peptides from both dynein intermediate chain (IC) and the Drosophila cargo protein Swallow (Swa) in the same grooves at the dimer interface; both GIQVD and KXTQT fingerprint sequences are recognized in the same groove. Swallow binds with higher affinity than IC, suggesting that LC8's binding to cargo proteins like Swallow serves a dimerization function independent of its role in dynein. |
X-ray crystallography, hydrogen isotope exchange NMR, isothermal titration calorimetry |
Journal of molecular biology |
High |
17570393
|
| 2008 |
DYNLL1 (LC8) binds IκBα and prevents its phosphorylation by IκB kinase (IKK), thereby inhibiting NF-κB activation. TNFα-induced reactive oxygen species oxidize LC8 to form an intermolecular disulfide bond between Cys2 residues, causing LC8 dissociation from IκBα. The thioredoxin-related protein TRP14 reduces oxidized LC8 to maintain its inhibitory function. |
Co-immunoprecipitation, in-cell NF-κB reporter assays, redox biochemistry, mutagenesis |
The Journal of biological chemistry |
High |
18579519
|
| 2008 |
Pak1 (residues 212-222) binds DYNLL1 (LC8) in the same canonical groove as nNOS and BimL, requiring the target-binding interface formed by LC8 dimerization. In vitro phosphorylation assays show Pak1 does not phosphorylate LC8 at Ser88 (which is inaccessible in the dimer), refuting the prior model; instead LC8 binding may modulate Pak1 activity and/or nuclear localization. |
NMR, X-ray crystallography, biochemical LC8 point mutants (K36P, T67A), in vitro phosphorylation assay |
The Journal of biological chemistry |
High |
18650427
|
| 2008 |
Phosphomimetic mutation in LC8 (DYNLL1) promotes dissociation to monomer and, by NMR backbone relaxation, the monomer shows more heterogeneous dynamics in residues forming the binding groove (beta1 and beta3 strands), suggesting dimerization pre-organizes the binding groove for ligand recognition. Peptide binding either retains (IC peptide) or silences (Swallow peptide) millisecond-microsecond dynamics in the groove, indicating ligand-specific conformational dynamics. |
15N NMR relaxation, equilibrium unfolding |
Biochemistry |
Medium |
18942858
|
| 2009 |
LC8 (DYNLL1) binds syntaphilin (SNPH) through a seven-residue LC8-binding motif, recruits to axonal mitochondria via SNPH, and enhances the SNPH-microtubule docking interaction to reduce mitochondrial mobility. Deletion of the LC8-binding motif on SNPH abolishes colocalization and impairs SNPH's ability to immobilize mitochondria. Circular dichroism shows LC8 stabilizes an alpha-helical coiled-coil in the SNPH microtubule-binding domain. |
Co-immunoprecipitation, mutagenesis, time-lapse live imaging in neurons, circular dichroism, fractionation |
The Journal of neuroscience |
High |
19641106
|
| 2009 |
LC8 (DYNLL1) interaction with Pak1 is required for EGF-induced nuclear import of Pak1 in MCF-7 cells, and this event is contingent on LC8-mediated Pak1 dimerization. Pak2, which lacks an LC8 binding site, remains cytoplasmic upon EGF stimulation. In zebrafish, developmental defects caused by Pak morpholino knockdown are partially rescued by wild-type Pak1 but not by Pak1 mutants disrupting either the LC8 binding or NLS sites. |
Fluorescence microscopy for nuclear import, zebrafish morpholino rescue, mutagenesis |
PloS one |
Medium |
19557173
|
| 2011 |
ASCIZ (ATMIN/ZNF822) is a transcriptional activator of the Dynll1 gene; DYNLL1 levels are reduced ~10-fold in ASCIZ-deficient human, mouse, and chicken cells. ASCIZ binds directly to the Dynll1 promoter in a Zn-finger-dependent manner. DYNLL1 protein in turn interacts with ten binding sites in the ASCIZ transcription activation domain, and high DYNLL1 levels inhibit ASCIZ transcriptional activity, forming a feedback loop. DYNLL1 is also required for DNA-damage-induced ASCIZ focus formation. |
ChIP, promoter reporter assay, co-IP, cell-based transcription assays across three cell types |
The Journal of biological chemistry |
High |
22167198
|
| 2011 |
LC8 (DYNLL1) binds Nek9 via a (K/R)XTQT motif adjacent to the Nek9 C-terminal coiled coil, causing Nek9 multimerization and increased Nek9 autoactivation. LC8 binding is regulated by Nek9 autophosphorylation on Ser944 immediately N-terminal to the motif. LC8 bound to Nek9 interferes with Nek9's interaction with its downstream partner Nek6 and with Nek6 activation, thus controlling signal transduction through the Nek9/Nek6/7 spindle kinase module. |
Co-immunoprecipitation, kinase activity assays, mutagenesis, size-exclusion chromatography |
The Journal of biological chemistry |
High |
21454704
|
| 2011 |
LC8 (DYNLL1) binds to multiple SQ/TQ motifs in the C-terminal domain of ATMIN/ASCIZ; co-expression of mCherry-DYNLL1 and GFP-ATMIN mutually affects intracellular protein localization, and DYNLL1 partially impedes DNA damage-induced ATMIN nuclear foci formation. |
Yeast two-hybrid, pepscan, NMR-modelled complexes, co-expression localization imaging |
Biochemical and biophysical research communications |
Medium |
21971545
|
| 2012 |
DYNLL1 (LC8) regulates B cell development downstream of ASCIZ: ASCIZ-deficient B cell precursors have highly reduced DYNLL1 levels, and ectopic Dynll1 expression restores normal B cell development. The B cell lymphopenia caused by ASCIZ absence can be fully suppressed by deletion of the proapoptotic DYNLL1 target Bim, placing DYNLL1 upstream of Bim-dependent apoptosis in developing B cells. |
Genetic rescue (ectopic Dynll1 expression), genetic epistasis (Bim knockout), flow cytometry of B cell populations in mice |
The Journal of experimental medicine |
High |
22891272
|
| 2012 |
LC8 (DYNLL1) binds tubulin, promotes microtubule assembly in vitro, and stabilizes microtubules in Drosophila embryos and HeLa cells. LC8 overexpression increases microtubule acetylation and resistance to cold/nocodazole-induced depolymerization; LC8 knockdown or inhibitory peptides destabilize microtubules, inhibit bipolar spindle assembly, and cause mitotic block in HeLa cells. |
In vitro microtubule assembly assay, immunofluorescence in Drosophila embryos and HeLa cells, siRNA knockdown, overexpression, molecular docking |
The Journal of biological chemistry |
Medium |
23038268
|
| 2013 |
Crystal structures of DYNLL1 (LC8) bound to Nek9 binding region peptides with and without phosphorylation on Ser944 reveal that phosphorylation of Ser944 (immediately N-terminal to the KXTQT motif) sterically and electrostatically reduces binding affinity of Nek9 to LC8, providing a structural mechanism for phosphorylation-regulated LC8-partner complex formation. |
X-ray crystallography, isothermal titration calorimetry, biophysical binding assays |
The Journal of biological chemistry |
High |
23482567
|
| 2013 |
LC8 (DYNLL1) inhibits RANKL-induced osteoclast differentiation, actin ring formation, and bone resorption by binding IκBα and preventing its phosphorylation and degradation, thereby suppressing NF-κB activation. LC8 also inhibits RANKL-induced JNK and ERK activation and downstream c-Fos and NFATc1 expression. LC8-transgenic mice show a mild osteopetrotic phenotype. |
Osteoclast differentiation assays, Western blotting, transgenic mouse phenotyping, ovariectomy bone loss model |
Journal of immunology |
Medium |
23293355
|
| 2014 |
DYNLL1 (LC8) mediates oligomerization of the Ana2 centriole duplication factor by binding two LC8-binding sites within Ana2; site 1 contains a TQT motif (Kd ~1.1 µM) and site 2 a TQC motif (Kd ~13 µM). Crystal structures show the Ana2 peptides form beta-strands extending a central LC8 beta-sandwich. LC8 dimers binding two Ana2 sites induce Ana2 tetramerization, yielding an Ana2M4-LC88 complex. |
X-ray crystallography (two independent structures), size-exclusion chromatography-multiangle light scattering, isothermal titration calorimetry, mutagenesis |
The Journal of biological chemistry |
High |
24920673
|
| 2014 |
Arl3 (GTP-bound) and LC8 (DYNLL1) together induce dissociation of dynactin from dynein. Immunoprecipitation and microtubule pull-down assays showed Arl3(Q71L) and LC8 facilitate dynactin detachment from dynein. LC8 interacts with dynein and Arl3 interacts with dynactin. siRNA knockdown of Arl3 and LC8 causes abnormal localizations of dynein, dynactin, and related organelles. |
Co-immunoprecipitation, microtubule pull-down, quantum dot-conjugated protein tracing, live-cell imaging, siRNA knockdown |
Nature communications |
Medium |
25342295
|
| 2015 |
Crystal structure of DYNLL1 (LC8) bound to a Chica spindle-adaptor peptide identifies a rigid TQT-LC8 anchor interaction coupled with flexible non-TQT interactions, establishing an 'anchored flexibility' model of LC8 motif recognition that explains both TQT requirement and sequence diversity tolerance. |
X-ray crystallography, NMR chemical shift/relaxation, isothermal titration calorimetry |
Biochemistry |
High |
26652654
|
| 2015 |
Ebola virus VP35 directly and with high affinity interacts with LC8 (DYNLL1). LC8 binding stabilizes the VP35 N-terminal oligomerization domain and enhances viral RNA synthesis. Mutational analysis of VP35 demonstrates the interaction is required for the functional effects of LC8 on RNA synthesis. |
Direct binding assay, minigenome viral RNA synthesis assay, mutagenesis of VP35 LC8-binding motif |
Journal of virology |
Medium |
25741013
|
| 2018 |
DYNLL1 is an inhibitor of DNA end resection: identified by CRISPR loss-of-function screen, DYNLL1 loss enables DNA end resection and restores homologous recombination in BRCA1-mutant cells. In vitro, DYNLL1 directly binds MRE11 to limit its end-resection activity. In cells, DYNLL1 associates with the MRN complex, BLM helicase, and DNA2 endonuclease to limit nucleolytic degradation of DNA ends. |
CRISPR loss-of-function screen, in vitro biochemical end-resection assay, co-immunoprecipitation, HR and NHEJ repair assays |
Nature |
High |
30464262
|
| 2018 |
DYNLL1 organizes multimeric 53BP1 complexes: DYNLL1 binding stimulates 53BP1 oligomerization and promotes 53BP1 recruitment to DSB-associated chromatin. DYNLL1 regulates 53BP1-dependent NHEJ including immunoglobulin class switch recombination (CSR); deletion of Dynll1 or its regulator Asciz, or mutation of DYNLL1 binding motifs in 53BP1, compromises CSR and renders Brca1 mutant cells resistant to PARP inhibitors. |
Co-immunoprecipitation, CSR assays, genetic deletion (Dynll1, Asciz), PARP inhibitor sensitivity assays in cells and tumors, 53BP1 oligomerization assay |
Nature communications |
High |
30559443
|
| 2018 |
DYNLL1 forms a high-affinity heterotetramer with the large myelin-associated glycoprotein (L-MAG) cytoplasmic domain; crystal structure shows 2:2 binding in a parallel arrangement. The DYNLL1-binding segment is near the L-MAG C-terminus adjacent to the Fyn kinase phosphorylation site. DYNLL1 dimerizes L-MAG but not S-MAG, implying an isoform-specific role in myelin-to-axon signaling. |
Yeast two-hybrid, in vitro binding with recombinant proteins, X-ray crystallography, small-angle X-ray scattering |
Journal of neurochemistry |
High |
30261098
|
| 2019 |
LC8 (DYNLL1) accumulates at laser-induced DNA damage tracks in a 53BP1-dependent manner, requiring the canonical H2AX-MDC1-RNF8-RNF168 signal transduction cascade. Genetic inactivation of LC8 or its interaction with 53BP1 causes checkpoint defects. Loss of LC8 alleviates hypersensitivity of BRCA1-depleted cells to ionizing radiation and PARP inhibition. |
Laser micro-irradiation and live-cell imaging, genetic inactivation (siRNA/CRISPR), checkpoint assays (γH2AX, Chk2 phosphorylation), PARP inhibitor sensitivity |
Nucleic acids research |
High |
30982887
|
| 2019 |
LC8/DYNLL1 (Drosophila Cut-up) is an essential component of the PICTS complex (Panoramix-Nxf2-Nxt1) required for piRNA-pathway co-transcriptional transposon silencing. LC8 drives PICTS complex dimerization through interaction with conserved motifs in Panoramix. Artificial dimerization of Panoramix bypasses the requirement for Ctp/LC8, demonstrating that LC8's role is to promote complex dimerization. |
Genetic knockout (loss of Ctp causes transposon de-repression and loss of H3K9me3 marks), artificial dimerization rescue, co-immunoprecipitation, tethering assay |
eLife |
High |
33538693
|
| 2019 |
LC8/DYNLL1 (rabies virus context) binds the disordered linker of the rabies virus phosphoprotein RavP adjacent to an endogenous dimerization domain, restricting RavP domain orientations and inducing a conformation similar to a more active viral polymerase cofactor state. LC8 interactions are essential for efficient viral polymerase functionality; RavP and LC8 colocalize in rabies-infected cells. |
NMR, SAXS, molecular modeling, viral minigenome assay, co-localization imaging |
Journal of molecular biology |
Medium |
31634467
|
| 2019 |
Phage display proteomic screen identifies 29 validated LC8 (DYNLL1) binding partners from the human proteome; all validated peptides contain the canonical TQT motif anchor. Residues outside the TQT anchor critically determine binding, enabling development of the LC8Pred algorithm with ~78% accuracy for predicting LC8-binding motifs. |
Proteomic phage display, isothermal titration calorimetry validation of 29 peptides, bioinformatic algorithm development |
Life science alliance |
Medium |
31266884
|
| 2020 |
DYNLL1 binds MRE11 and disrupts the MRE11 dimer to limit DNA end resection. The Shieldin complex is recruited to DSBs hours after DYNLL1, predominantly in G1 cells, and its localization depends on MRE11 activity and is regulated by the DYNLL1-MRE11 interaction. Constitutive association of DYNLL1 with MRE11 can resensitize Shieldin-deficient BRCA1-null cells to PARP inhibitors. |
Co-immunoprecipitation, DSB localization assays, PARP inhibitor sensitivity, cell-cycle analysis |
Nature structural & molecular biology |
High |
37696958
|
| 2020 |
Dynll1 forms a persistent complex with mitochondrial cytochrome oxidase Cox4i1 in dendritic cells. Pathogen (Listeria monocytogenes) infection disturbs the Dynll1-Cox4i1 complex; dissociation of this complex is required for release of mitochondrial reactive oxygen species and regulation of intracellular bacterial proliferation. Dynll1 functions as an inhibitor of mitochondrial ROS production. |
Mass spectrometry, co-immunoprecipitation, ROS measurement, bacterial proliferation assay in dendritic cells |
Infection and immunity |
Medium |
32041786
|
| 2020 |
LC8 (DYNLL1) binds predominantly in-register to the multivalent IDP domain of ASCIZ (which has three LC8 recognition motifs); at substoichiometric concentrations, one motif is preferentially bound. Linker length between motifs and motif specificity drive the in-register binding mode. |
NMR chemical shift perturbation, analytical ultracentrifugation, native electrospray ionization mass spectrometry, saturation transfer difference NMR |
The Journal of biological chemistry |
Medium |
32139510
|
| 2021 |
ASCIZ and DYNLL1 are essential for development and expansion of MYC-driven B cell lymphoma. DYNLL1 levels are co-activated by ASCIZ and MYC. Deletion of Asciz or Dynll1 prevented abnormal pre-B cell expansion in pre-cancerous Eµ-Myc mice, potentiated MYC-induced apoptosis, and delayed lymphoma development; induced deletion of Asciz in established lymphomas extended survival. |
Genetic deletion (constitutive and inducible) in Eµ-Myc mouse lymphoma model, flow cytometry, apoptosis assays |
Cell reports |
High |
26832406
|
| 2005 |
DYNLL1 (DNCL1) interacts with the C-terminal domain of PAX6 transcription factor; three PAX6 C-terminal mutations found in patients with eye malformations reduce or abolish the PAX6-DNCL1 interaction, suggesting this interaction may be relevant to PAX6-dependent neurological function. |
Yeast two-hybrid library screen, mutagenesis of PAX6 patient alleles |
BMC genetics |
Low |
16098226
|
| 2008 |
In nitrergic varicosities of mouse gut, LC8 (DYNLL1/PIN) is associated with all cytosolic forms of nNOS (320-, 250-, 155-kDa) but is absent from membrane-associated nNOS. All cytosolic nNOS associated with LC8 is catalytically inactive and serine847-phosphorylated. LC8 does not associate with calmodulin-bound (active) nNOS, suggesting LC8 may transport inactive nNOS to the membrane where it dissociates. |
Co-immunoprecipitation, subcellular fractionation, in vitro nitric oxide assay |
American journal of physiology. Gastrointestinal and liver physiology |
Medium |
18635601
|
| 2010 |
DYNLL1 directly interacts with two newly characterized targets — African swine fever virus protein p54 and the postsynaptic scaffolding protein gephyrin — through motifs homologous to GIQVD or KXTQT consensus sequences. NMR demonstrates direct interaction and structural modeling shows the overall binding mode is preserved as in other complexes, despite residue-level differences. |
NMR binding experiments, structural modeling |
FEBS letters |
Medium |
21094642
|
| 2022 |
DLEU1 lncRNA promotes cell survival in esophageal squamous cell carcinoma by binding and stabilizing DYNLL1 protein, interfering with RNF114-mediated ubiquitination and proteasomal degradation of DYNLL1. The DLEU1/DYNLL1 axis upregulates antiapoptotic BCL2. This identifies RNF114 as an E3 ubiquitin ligase that can target DYNLL1 for proteasomal degradation. |
RNA pulldown, co-immunoprecipitation, ubiquitination assay, siRNA knockdown, xenograft tumor models |
Journal of translational medicine |
Medium |
35619131
|